These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25404386)

  • 1. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.
    Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P
    BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia.
    Geilswijk M; Andersen LL; Frost M; Brusgaard K; Beck-Nielsen H; Frederiksen AL; Jensen DM
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: A particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections.
    Barsi Á; Beke A; Sármán B
    Front Endocrinol (Lausanne); 2022; 13():964481. PubMed ID: 36187120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with the somatostatin analogue SMS 201-995: alternative to pancreatectomy in persistent hyperinsulinaemic hypoglycaemia of infancy.
    Glaser B; Landaw H
    Digestion; 1990; 45 Suppl 1():27-35. PubMed ID: 2185966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Hyperinsulinemic Hypoglycemia in a Neonate: Response to Sirolimus Therapy.
    Méder Ü; Bokodi G; Balogh L; Körner A; Szabó M; Pruhova S; Szabó AJ
    Pediatrics; 2015 Nov; 136(5):e1369-72. PubMed ID: 26504129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal hyperinsulinemic hypoglycemia. Two case reports.
    Zaffanello M; Zamboni G; Maffeis C; Antoniazzi F; Tatò L
    Minerva Pediatr; 2002 Aug; 54(4):325-33. PubMed ID: 12131869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
    Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
    Kuno T; Fujita I; Ohta M; Kanemitsu H; Miyazaki S; Miyamoto S
    Endocr J; 1999 Mar; 46 Suppl():S47-9. PubMed ID: 12054118
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
    Clark W; O'Donovan D
    Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe and prolonged hypoglycemia triggered by long-acting octreotide in a patient with malignant mesenchymal tumor: case report.
    Sari R; Altunbas H; Ozdogan M; Gurer EI; Karayalcin U
    J Chemother; 2003 Feb; 15(1):85-8. PubMed ID: 12678421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Octreotide LAR was useful for avoiding hypoglycemia in an elderly patient with insulinoma].
    Kanno A; Ide K; Kurita K; Terano T; Yamamoto K
    Nihon Ronen Igakkai Zasshi; 2017; 54(2):172-178. PubMed ID: 28592737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged hyperinsulinemic hypoglycemia in a small for date preterm.
    Pezzati M; Barni S; Chiti G; Danesi G; Rubaltelli FF
    Minerva Pediatr; 2003 Feb; 55(1):79-82. PubMed ID: 12660630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinemic hypoglycemia syndrome associated with mutations in the human insulin receptor gene: report of two cases.
    Kuroda Y; Iwahashi H; Mineo I; Fukui K; Fukuhara A; Iwamoto R; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):353-62. PubMed ID: 25753915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hyperinsulinemic hypoglycemia of infancy.
    Desai MP; Khatri JV
    Indian Pediatr; 1998 Apr; 35(4):317-28. PubMed ID: 9770886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
    DeClue TJ; Malone JI; Bercu BB
    J Pediatr; 1990 May; 116(5):747-50. PubMed ID: 2184212
    [No Abstract]   [Full Text] [Related]  

  • 18. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Courbon F; Caron P
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):904-11. PubMed ID: 18031316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is octreotide a risk factor in necrotizing enterocolitis?
    Reck-Burneo CA; Parekh A; Velcek FT
    J Pediatr Surg; 2008 Jun; 43(6):1209-10. PubMed ID: 18558210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.